Stevanato Group SpA STVN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management
-
Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting
-
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026
-
Stevanato Group to Participate in Three Upcoming Investor Conferences
-
Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026
Trading Information
- Previous Close Price
- $16.63
- Day Range
- $16.27–17.17
- 52-Week Range
- $12.89–28.00
- Bid/Ask
- $16.78 / $16.85
- Shares Outstanding
- 273.00M
- Market Cap
- $4.59B
- Volume/Avg
- 283,485 / 516,946
Key Statistics
- Price/Earnings (Normalized)
- 28.21
- Price/Sales
- 3.34
- Dividend Yield (Trailing)
- 0.35%
- Dividend Yield (Forward)
- 0.34%
- Total Yield
- 0.37%
Company Profile
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 5,795
- Website
- https://www.stevanatogroup.com
Valuation
|
Metric
|
STVN
|
|---|---|
Price/Earnings (Normalized) | 28.21 |
Price/Book Value | 2.66 |
Price/Sales | 3.34 |
Price/Cash Flow | 16.21 |
Price/Earnings
STVN
Financial Strength
|
Metric
|
STVN
|
|---|---|
Quick Ratio | 1.11 |
Current Ratio | 1.63 |
Interest Coverage | 31.83 |
Quick Ratio
STVN
Profitability
|
Metric
|
STVN
|
|---|---|
Return on Assets (Normalized) | 6.11% |
Return on Equity (Normalized) | 10.26% |
Return on Invested Capital (Normalized) | 8.10% |
Return on Assets
STVN
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Rvtgxfvhs | Brqz | $146B | |||
| Becton Dickinson & Co
BDX
| Jsfvg | Lnglfj | $40B | |||
| Alcon Inc
ALC
| Fbzpllfyb | Tlgpv | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| Pktvmrpf | Kwgxwq | $31B | |||
| ResMed Inc
RMD
| Jjfcftkxt | Fkklt | $28B | |||
| West Pharmaceutical Services Inc
WST
| Vgftfsvwf | Sbqv | $23B | |||
| Solventum Corp
SOLV
| Wlwrbjsp | Cthw | $14B | |||
| The Cooper Companies Inc
COO
| Nrybqbcx | Zjbhjl | $13B | |||
| Align Technology Inc
ALGN
| Sgbkpcqyb | Psmcdzq | $13B | |||
| Baxter International Inc
BAX
| Dlws | Mrdhvf | $11B |
United States